Toru Mimura

1.1k total citations
37 papers, 862 citations indexed

About

Toru Mimura is a scholar working on Molecular Biology, Virology and Organic Chemistry. According to data from OpenAlex, Toru Mimura has authored 37 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Virology and 13 papers in Organic Chemistry. Recurrent topics in Toru Mimura's work include HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (12 papers) and Carbohydrate Chemistry and Synthesis (12 papers). Toru Mimura is often cited by papers focused on HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (12 papers) and Carbohydrate Chemistry and Synthesis (12 papers). Toru Mimura collaborates with scholars based in Japan, United States and France. Toru Mimura's co-authors include Toshiyuki Uryu, Yutaro Kaneko, Hideki Nakashima, Naoki Yamamoto, Takashi Yoshida, Osamu Yoshida, Kenichi Hatanaka, Kaname Katsuraya, Takashi Yoshida and Jean‐Claude Romano and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Applied and Environmental Microbiology.

In The Last Decade

Toru Mimura

36 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toru Mimura Japan 18 307 261 201 156 148 37 862
Youngmin Jeon South Korea 11 434 1.4× 47 0.2× 214 1.1× 148 0.9× 145 1.0× 15 1.1k
Eric Condamine France 15 260 0.8× 225 0.9× 83 0.4× 12 0.1× 18 0.1× 42 694
Martin Willemoës Denmark 24 1.1k 3.5× 82 0.3× 191 1.0× 12 0.1× 130 0.9× 59 1.6k
Norma Silvia Sánchez Mexico 14 280 0.9× 48 0.2× 95 0.5× 9 0.1× 50 0.3× 34 532
S.‐C. Kuo United States 13 520 1.7× 74 0.3× 156 0.8× 10 0.1× 33 0.2× 15 740
C.R. Santos Brazil 21 452 1.5× 56 0.2× 250 1.2× 15 0.1× 14 0.1× 38 944
Kenneth W. Talmadge United States 14 635 2.1× 68 0.3× 1.1k 5.4× 9 0.1× 12 0.1× 22 1.7k
Andrzej Łyskowski Austria 20 632 2.1× 146 0.6× 96 0.5× 38 0.2× 13 0.1× 37 1.1k
Andrés G. Salvay Argentina 19 258 0.8× 35 0.1× 121 0.6× 6 0.0× 26 0.2× 41 905
Philippe Talaga France 17 350 1.1× 97 0.4× 331 1.6× 3 0.0× 53 0.4× 27 990

Countries citing papers authored by Toru Mimura

Since Specialization
Citations

This map shows the geographic impact of Toru Mimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru Mimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru Mimura more than expected).

Fields of papers citing papers by Toru Mimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toru Mimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru Mimura. The network helps show where Toru Mimura may publish in the future.

Co-authorship network of co-authors of Toru Mimura

This figure shows the co-authorship network connecting the top 25 collaborators of Toru Mimura. A scholar is included among the top collaborators of Toru Mimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toru Mimura. Toru Mimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hino, Toshiaki, Shota Tanaka, Toru Mimura, et al.. (2025). Characterization of H3K4me3 in mouse oocytes at the metaphase II stage. Journal of Biological Chemistry. 301(7). 110308–110308.
2.
Lü, Rong, Takashi Yoshida, Hiroshi Nakashima, et al.. (2000). Specific biological activities of Chinese lacquer polysaccharides. Carbohydrate Polymers. 43(1). 47–54. 38 indexed citations
3.
Yoshida, Takashi, Tsukasa Akasaka, Kazuyuki Hattori, et al.. (1999). Synthesis of polymethacrylate derivatives having sulfated maltoheptaose side chains with anti-HIV activities. Journal of Polymer Science Part A Polymer Chemistry. 37(6). 789–800. 41 indexed citations
4.
Gao, Ying, Kaname Katsuraya, Yutaro Kaneko, et al.. (1999). Synthesis, Enzymatic Hydrolysis, and Anti-HIV Activity of AZT−Spacer−Curdlan Sulfates. Macromolecules. 32(25). 8319–8324. 18 indexed citations
5.
Hattori, Kazuyuki, Takashi Yoshida, Hideki Nakashima, et al.. (1998). Synthesis of sulfonated amino-polysaccharides having anti-HIV and blood anticoagulant activities. Carbohydrate Research. 312(1-2). 1–8. 28 indexed citations
6.
Gao, Ying, Kaname Katsuraya, Yutaro Kaneko, et al.. (1998). Synthesis of Azidothymidine-Bound Curdlan Sulfate with Anti-Human Immunodeficiency Virus Activity in vitro. Polymer Journal. 30(1). 31–36. 11 indexed citations
7.
Katsuraya, Kaname, et al.. (1997). NMR Studies on Interactions between a Sulfated Polysaccharide Heparin and a Protein Model Compound.. Sen i Gakkaishi. 53(12). 533–539. 2 indexed citations
8.
Lu, Rong, Kazuyuki Hattori, Takashi Yoshida, et al.. (1997). Synthesis of Sulfated Deoxy-Ribofuranans Having Selective Anti-AIDS Virus Activity by Ring-Opening Copolymerization of 1,4-Anhydro Ribose Derivatives. Polymer Journal. 29(4). 374–379. 6 indexed citations
9.
10.
Gordon, M. Kathleen, et al.. (1995). Further clinical studies of curdlan sulfate (CRDS)--an anti-HIV agent.. PubMed. 26(3-4). 97–131. 15 indexed citations
11.
Yoshida, Takashi, Yuichi Yasuda, Toru Mimura, et al.. (1995). Synthesis of curdlan sulfates having inhibitory effects in vitro against AIDS viruses HIV-1 and HIV-2. Carbohydrate Research. 276(2). 425–436. 78 indexed citations
12.
13.
Yoshida, Takashi, Yuichi Yasuda, Toshiyuki Uryu, et al.. (1994). Synthesis and in vitro Inhibitory Effect of L-Glycosyl-Branched Curdlan Sulfates on AIDS Virus Infection. Macromolecules. 27(22). 6272–6276. 22 indexed citations
14.
Gordón, Mónica, et al.. (1994). A phase I study of curdlan sulfate--an HIV inhibitor. Tolerance, pharmacokinetics and effects on coagulation and on CD4 lymphocytes.. PubMed. 25(3-4). 163–80. 32 indexed citations
15.
Kai, Akira, Kenichi Hatanaka, Toshihiro Akaike, et al.. (1993). Biosynthesis of curdlan from culture media containing 13C-labeled glucose as the carbon source. Carbohydrate Research. 240. 153–159. 17 indexed citations
16.
Hatanaka, Kenichi, Toshiyuki Uryu, Osamu Yoshida, et al.. (1991). A strong inhibition of HIV-induced cytopathic effects by synthetic (1→6)-α-d-mannopyranan sulfate. Carbohydrate Research. 214(1). 147–154. 15 indexed citations
17.
Yamamoto, I., Kenichiro MATSUZAKI, Kenichi Hatanaka, et al.. (1990). Synthesis, structure and antiviral activity of sulfates of cellulose and its branched derivatives. Carbohydrate Polymers. 14(1). 53–63. 45 indexed citations
18.
Yoshida, Takashi, Kenichi Hatanaka, Toshiyuki Uryu, et al.. (1990). Synthesis and structural analysis of curdlan sulfate with a potent inhibitory effect in vitro of AIDS virus infection. Macromolecules. 23(16). 3717–3722. 97 indexed citations
19.
Hatanaka, Kenichi, Takashi Yoshida, Toshiyuki Uryu, et al.. (1989). Synthesis of an Inhibitor of Human Immunodeficiency Virus Infection. Japanese Journal of Cancer Research. 80(2). 95–98. 29 indexed citations
20.
Nakashima, Hideki, Osamu Yoshida, Tadafumi S. Tochikura, et al.. (1987). Sulfation of polysaccharides generates potent and selective inhibitors of human immunodeficiency virus infection and replication in vitro.. PubMed. 78(11). 1164–8. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youngmin Jeon Breakdown of academic impact, for papers by Eric Condamine Breakdown of academic impact, for papers by Martin Willemoës Breakdown of academic impact, for papers by Norma Silvia Sánchez Breakdown of academic impact, for papers by S.‐C. Kuo Breakdown of academic impact, for papers by C.R. Santos Breakdown of academic impact, for papers by Kenneth W. Talmadge Breakdown of academic impact, for papers by Andrzej Łyskowski Breakdown of academic impact, for papers by Andrés G. Salvay Breakdown of academic impact, for papers by Philippe Talaga
Rankless by CCL
2026